Global Acne Medication Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Acne Medication Sales Market Report 2024
Market Analysis and InsightsGlobal Acne Medication Market
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
Due to the COVID-19 pandemic, the global Acne Medication market size is estimated to be worth US$ 3616.6 million in 2024 and is forecast to a readjusted size of US$ 4592.8 million by 2034 with a CAGR of 3.4% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Topical Medication accounting for % of the Acne Medication global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
Global Acne Medication Scope and Market Size
The global Acne Medication market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Acne Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Topical Medication
Oral Medication
Hospital Pharmacies
Drugstore
Online Retail
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Stiefel
GALDERMA
VALEANT
Allergan
TEVA
Mylan
Mayne Pharma
HUAPONT PHARM
SPH
SUN PHARMA
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
Due to the COVID-19 pandemic, the global Acne Medication market size is estimated to be worth US$ 3616.6 million in 2024 and is forecast to a readjusted size of US$ 4592.8 million by 2034 with a CAGR of 3.4% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Topical Medication accounting for % of the Acne Medication global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
Global Acne Medication Scope and Market Size
The global Acne Medication market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Acne Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Topical Medication
Oral Medication
Segment by Application
Hospital Pharmacies
Drugstore
Online Retail
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Stiefel
GALDERMA
VALEANT
Allergan
TEVA
Mylan
Mayne Pharma
HUAPONT PHARM
SPH
SUN PHARMA
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices